Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro

被引：11

作者：

Amrein, Lilian ^{[1
,2
]}

Panasci, Lawrence ^{[1
,2
]}

Gibson, Spencer B. ^{[3
]}

Johnston, James B. ^{[3
]}

Soulieres, Denis ^{[4
,5
]}

Aloyz, Raquel ^{[1
,2
]}

机构：

[1] McGill Univ, Lady Davis Inst Med Res, Sir MB Davis Jewish Gen Hosp, Canc Segal Ctr, Montreal, PQ, Canada

[2] McGill Univ, Montreal Ctr Expt Therapeut, Montreal, PQ, Canada

[3] Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada

[4] Cent Hosp Univ Montreal, Dept Med, Serv Hematol & Med Oncol, Montreal, PQ, Canada

[5] Hop St Justine, Ctr Rech, CHUM, Montreal, PQ H3T 1C5, Canada

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2009年 / 147卷 / 03期

关键词：

chronic lymphocytic leukaemia; p53; del; 17; dasatinib; CELL; CHLORAMBUCIL; APOPTOSIS; KINASE;

D O I：

10.1111/j.1365-2141.2009.07814.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：396 / 398

页数：3

共 10 条

[1] Imatinib sensitizes CLL lymphocytes to chlorambucil [J].

Aloyz, R ;

Grzywacz, K ;

Xu, ZY ;

Loignon, M ;

Alaoui-Jamali, MA ;

Panasci, L .

LEUKEMIA, 2004, 18 (03) :409-414

[2]

Amrein L, 2008, BRIT J HAEMATOL, V143, P698, DOI [10.1111/j.1365-2141.2008.07418.x, 10.1111/j.1365-2141.2008.07418.x ]

[3]

Amrein PC, 2008, BLOOD, V112, P1084

[4] Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis [J].

Contri, A ;

Brunati, AM ;

Trentin, L ;

Cabrelle, A ;

Miorin, M ;

Cesaro, L ;

Pinna, LA ;

Zambello, R ;

Semenzato, G ;

Donella-Deana, A .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :369-378

[5] Chronic lymphocytic leukaemia: the nature of the leukaemic cell [J].

Hamblin, TJ ;

Oscier, DG .

BLOOD REVIEWS, 1997, 11 (03) :119-128

[6] p53 dysfunction in B-cell chronic lymphocytic leukemia:: inactivation of ATM as an alternative to TP53 mutation [J].

Pettitt, AR ;

Sherrington, PD ;

Stewart, G ;

Cawley, JC ;

Taylor, AMR ;

Stankovic, T .

BLOOD, 2001, 98 (03) :814-822

[7] Dasatinib induces a response in chronic lymphocytic leukemia [J].

Pitini, Vincenzo ;

Arrigo, Carmela ;

Altavilla, Giuseppe .

BLOOD, 2009, 113 (02) :498-498

[8] p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism [J].

Steele, Andrew J. ;

Prentice, Archibald G. ;

Hoffbrand, A. Victor ;

Yogashangary, Birunthini C. ;

Hart, Stephen M. ;

Nacheva, Elisabeth P. ;

Howard-Reeves, Julie D. ;

Duke, Veronique M. ;

Kottaridis, Panagiotis D. ;

Cwynarski, Kate ;

Vassilev, Lyubomir T. ;

Wickremasinghe, R. Gitendra .

BLOOD, 2008, 112 (09) :3827-3834

[9] DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia [J].

Willmore, Elaine ;

Elliott, Sarah L. ;

Mainou-Fowler, Tryfonia ;

Summerfield, Geoffrey R. ;

Jackson, Graham H. ;

O'Neill, Fran ;

Lowe, Christopher ;

Carter, Anthony ;

Harris, Robert ;

Pettitt, Andrew R. ;

Cano-Soumillac, Celine ;

Griffin, Roger J. ;

Cowell, Ian G. ;

Austin, Caroline A. ;

Durkacz, Barbara W. .

CLINICAL CANCER RESEARCH, 2008, 14 (12) :3984-3992

[10] Chronic lymphocytic leukemia and treatment resistance in cancer The role of the p53 pathway [J].

Zenz, Thorsten ;

Benner, Axel ;

Doehner, Hartmut ;

Stilgenbauer, Stephan .

CELL CYCLE, 2008, 7 (24) :3810-3814

← 1 →